A detailed history of Creative Planning transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Creative Planning holds 38,938 shares of RVMD stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,938
Previous 65,714 40.75%
Holding current value
$2.64 Million
Previous $2.42 Million 24.78%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$34.7 - $46.7 $929,127 - $1.25 Million
-26,776 Reduced 40.75%
38,938 $1.82 Million
Q2 2025

Aug 08, 2025

BUY
$31.13 - $41.98 $641,776 - $865,459
20,616 Added 45.71%
65,714 $2.42 Million
Q1 2025

May 15, 2025

BUY
$35.36 - $44.42 $60,571 - $76,091
1,713 Added 3.95%
45,098 $1.59 Million
Q4 2024

Feb 14, 2025

BUY
$42.97 - $60.6 $237,065 - $334,330
5,517 Added 14.57%
43,385 $1.9 Million
Q3 2024

Oct 11, 2024

BUY
$36.92 - $47.94 $400,175 - $519,621
10,839 Added 40.1%
37,868 $1.72 Million
Q2 2024

Aug 15, 2024

BUY
$30.14 - $40.68 $321,503 - $433,933
10,667 Added 65.19%
27,029 $1.05 Million
Q1 2024

May 10, 2024

BUY
$26.56 - $33.55 $434,574 - $548,945
16,362 New
16,362 $527,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.94B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.